Atlas Trials

Pharmacodynamics of a Fixed Dose Combination of 0.34% Tropicamide and 2.5% Phenylephrine Hydrochloride, Eye Drop, Solution

Clinical trial NCT07075224 · COMPLETED

Trial details

NCT number
NCT07075224
Sponsor
Unither Pharmaceuticals, France
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Mydriasis
Start date
2025-11-01
Primary completion
2025-11-09
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.